Number of the records: 1  

Joint analysis of phenotypic and genomic diversity sheds light on the evolution of xenobiotic metabolism in humans

  1. 1.
    SYSNO ASEP0566038
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleJoint analysis of phenotypic and genomic diversity sheds light on the evolution of xenobiotic metabolism in humans
    Author(s) Mouterde, M. (CH)
    Daali, Y. (CH)
    Rollason, V. (CH)
    Čížková, Martina (ARU-G) RID, SAI, ORCID
    Mulugeta, A. (ET)
    Al Balushi, K. A. (OM)
    Fakis, G. (GR)
    Constantinidis, T. C. (GR)
    Al-Thihli, K. (OM)
    Černá, M. (CZ)
    Makonnen, E. (ET)
    Boukouvala, S. (GR)
    Al-Yahyaee, S. (OM)
    Yimer, G. (US)
    Černý, V. (CZ)
    Desmeules, J. (CH)
    Poloni, E. S. (CH)
    Number of authors17
    Article numberevac167
    Source TitleGenome Biology and Evolution. - : Oxford University Press - ISSN 1759-6653
    Roč. 14, č. 12 (2022)
    Number of pages23 s.
    Publication formOnline - E
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsADME genes ; drug metabolism phenotypes ; genome-wide association studies ; genome-wide selection scans ; human evolution
    OECD categoryBiology (theoretical, mathematical, thermal, cryobiology, biological rhythm), Evolutionary biology
    Method of publishingOpen access
    Institutional supportARU-G - RVO:67985912
    UT WOS000898899200001
    EID SCOPUS85153965696
    DOI10.1093/gbe/evac167
    AnnotationVariation in genes involved in the absorption, distribution, metabolism, and excretion of drugs (ADME) can influence individual response to a therapeutic treatment. The study of ADME genetic diversity in human populations has led to evolutionary hypotheses of adaptation to distinct chemical environments. Population differentiation in measured drug metabolism phenotypes is, however, scarcely documented, often indirectly estimated via genotype-predicted phenotypes. We administered seven probe compounds devised to target six cytochrome P450 enzymes and the P-glycoprotein (P-gp) activity to assess phenotypic variation in four populations along a latitudinal transect spanning over Africa, the Middle East, and Europe (349 healthy Ethiopian, Omani, Greek, and Czech volunteers). We demonstrate significant population differentiation for all phenotypes except the one measuring CYP2D6 activity. Genome-wide association studies (GWAS) evidenced that the variability of phenotypes measuring CYP2B6, CYP2C9, CYP2C19, and CYP2D6 activity was associated with genetic variants linked to the corresponding encoding genes, and additional genes for the latter three. Instead, GWAS did not indicate any association between genetic diversity and the phenotypes measuring CYP1A2, CYP3A4, and P-gp activity. Genome scans of selection highlighted multiple candidate regions, a few of which included ADME genes, but none overlapped with the GWAS candidates. Our results suggest that different mechanisms have been shaping the evolution of these phenotypes, including phenotypic plasticity, and possibly some form of balancing selection. We discuss how these contrasting results highlight the diverse evolutionary trajectories of ADME genes and proteins, consistent with the wide spectrum of both endogenous and exogenous molecules that are their substrates.
    WorkplaceInstitute of Archaeology (Prague)
    ContactLada Šlesingerová, slesingerova@arup.cas.cz, Tel.: 257 014 412
    Year of Publishing2023
    Electronic addresshttps://doi.org/10.1093/gbe/evac167
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.